** All times indicated below are Pacific Time **
(subject to updating)
Sunday, August 11, 2024 | ||
12:00PM | Registration | |
Session I: CLTI Mini Symposium Moderators: Michael Conte, MD & Joseph Mills, MD |
||
1:00PM | Welcome/Overview | Michael Conte, MD |
1:10 | Initial evaluation of the Neuro-ischemic Foot- the value of an organized approach | Clara Gomez-Sanchez, MD Monara Dini, DPM |
1:40 | Pedal acceleration time and pedal calcium score-will they change your management | Iris Liu, MD |
1:55 | Complex BTK disease- what does and doesn’t really work? | Venita Chandra, MD |
2:15 | Drug therapy for BTK disease-paclitaxel or limus, with or without a scaffold | Peter Schneider, MD |
2:35 | Screening for PAD in at-risk patients—how can this be accomplished? | Leigh Ann O’Banion, MD |
2:50 | Q&A / Panel | |
3:00 | Coffee Break in Exhibit Hall | |
Session II Moderators: Venita Chandra, MD & Alexander Reyzelman, DPM |
||
3:30 | Keynoter Speaker—The Evolution of management of CLTI | Joseph Mills, MD |
4:00 | Foot reconstruction in DFU- when, who, and by whom? | Alexander Reyzelman, DPM |
4:15 | Complex wound management after revascularization | Scott Hansen, MD |
4:30 | Establishing a DVA program-patient selection and technical tips | Shant Vartanian, MD |
4:45 | Debate: DVA is a valuable tool in the rx of today’s CLTI patients | Joseph Mills, MD |
DVA is interesting, but it’s still research | Michael Conte, MD | |
5:05 | Case presentations from trainee to panel |
Sowmya Mangipudi, MD Panel: |
5:30 | Adjourn | |
5:30PM | Wine Tasting Reception in Exhibit Hall | |
Monday, August 12, 2024 | ||
7:00AM | Registration and Continental Breakfast | |
Session III: UCSF-STANFORD Aortic Session Moderator: Jason T. Lee, MD and Jade Hiramoto, MD |
||
TYPE B AORTIC DISSECTION | ||
8:00 | Introduction and Overview | |
8:10 | Reporting Guidelines and Anatomic Updates for Type B Dissection | Joseph Lombardi, MD |
8:40 | Acute Complicated Type B Aortic Dissections – Approach by vascular bed | Sukgu Han, MD |
9:00 | Considerations in patients with Connective Tissue Disorders | Sherene Shalhub, MD |
9:20 | Debate: Most Type B should be managed medically | Jade Hiramoto, MD |
Debate: Not so! Here are risk factors and when we should treat | Joseph Lombardi, MD | |
9:40 | Approach to malperfusion in Type A aortic dissection | Barbara Hamilton, MD |
10:00 | Coffee Break in Exhibit Hall | |
Session IV: ARCH PATHOLOGIES Moderators: Jason T. Lee, MD & Jade Hiramoto, MD |
||
10:30 | How to do it: experience with thoracic side branch | Jason Lee, MD |
10:45 | How to do it: early experience with modified devices | Sukgu Han, MD |
11:00 | How to do it: When to choose IDE devices: Lessons from ARC | Warren Gasper, MD |
11:15 | Case presentations from trainees to panel |
Arash Fereydooni, MD Panel: |
12:00PM | Adjourn | |
Tuesday, August 13, 2024 | ||
7:00AM | Registration and Continental Breakfast | |
Session V: Vascular Practice Issues 2024 Moderators: Allan Conway, MD & Raj Sarkar, MD |
||
8:00 | Using the VQI for Good | James Iannuzzi, MD |
8:30 | Venous Thrombectomy – New Devices Are Available – Should We Be Using Them? | Jaehoon Shin, MD |
8:50 | Gonadal Vein Transposition for Nutcracker Syndrome | Clara Gomez-Sanchez, MD |
9:05 | Saphenous vein ablation versus preservation- guidelines and practice | Raj Sarkar, MD |
9:20 | Debate: Carotid revascularization- This is What I Prefer to Offer to Standard Risk Patients | |
Case Presentation | Charles Eichler, MD | |
Carotid Endarterectomy | Robert Chang, MD | |
TCAR | Mahmoud Malas, MD | |
Transfemoral CAS | Daniel Cooke, MD | |
9:50 | Q&A | |
10:00 | Coffee Break in Exhibit Hall | |
Session VI Moderator: Shant Vartanian, MD |
||
10:30 | OBL – Is This a Necessity For Survival in Today’s Practice? Percutaneous AVF’s – Value added or trendy innovation? | Raj Sarkar, MD |
10:50 | Percutaneous AVF’s – Value added or trendy innovation? | Shant Vartanian, MD |
11:10 | Modern trends in Hemodialysis access | Bart Dolmatch, MD |
11:40 | Q&A | |
11:55 | Final Announcements | Michael Conte, MD |
12:00PM | Adjourn |